2020
DOI: 10.3390/cancers12061657
|View full text |Cite
|
Sign up to set email alerts
|

Two-Dimensional Theranostic Nanomaterials in Cancer Treatment: State of the Art and Perspectives

Abstract: As the combination of therapies enhances the performance of biocompatible materials in cancer treatment, theranostic therapies are attracting increasing attention rather than individual approaches. In this review, we describe a variety of two-dimensional (2D) theranostic nanomaterials and their efficacy in ablating tumors. Though many literature reports are available to demonstrate the potential application of 2D nanomaterials, we have reviewed here cancer-treating therapies based on such multifunctional nanom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 23 publications
(14 citation statements)
references
References 130 publications
(198 reference statements)
0
14
0
Order By: Relevance
“…Additionally, MnO 2 chemical properties predestine this compound to be a base for theranostic solutions. Due to the specific conditions characteristic for tumour microenvironment (TME)—low pH, high GSH level and H 2 O 2 concentration [ 34 , 35 ]—MnO 2 NPs can play a role as a carrier of chosen drug that can be released after the dissolution of NPs into Mn 2+ [ 36 ]. Released Mn 2+ ions can react with H 2 O 2 present in the TME, decreasing hypoxia and changing the environment to be less favourable for tumour cells.…”
Section: Medical Applications Of Manganese and Manganese Oxide Nanoparticlesmentioning
confidence: 99%
“…Additionally, MnO 2 chemical properties predestine this compound to be a base for theranostic solutions. Due to the specific conditions characteristic for tumour microenvironment (TME)—low pH, high GSH level and H 2 O 2 concentration [ 34 , 35 ]—MnO 2 NPs can play a role as a carrier of chosen drug that can be released after the dissolution of NPs into Mn 2+ [ 36 ]. Released Mn 2+ ions can react with H 2 O 2 present in the TME, decreasing hypoxia and changing the environment to be less favourable for tumour cells.…”
Section: Medical Applications Of Manganese and Manganese Oxide Nanoparticlesmentioning
confidence: 99%
“…This has led to the establishment of a new multi-disciplinary research domain known as theranostics. Examples of theranostic nanomaterials are iron-based metal oxide magnetic nanocrystals, MXene, black phosphorus (BP), graphene oxide (GO), manganese dioxide (MnO 2 ), and palladium (Pd) [ 5 , 6 ]. In addition to those, an emerging class of materials with theranostic potential is represented by nanozymes (NZs).…”
Section: Introductionmentioning
confidence: 99%
“…As a result, 2D nanomaterials were extensively applied in various biomedical applications, such as, in drug/gene delivery, tissue engineering, biosensors, biomedical imaging, etc. One of the important feature of the 2D nanomaterials is having larger specific area that allows adsorption/absorption of various small molecules, including drugs, photosensitizing molecules, and functional nanoparticles. Dimensionality and the planar structure of 2D nanomaterials are the most influential material parameters, which allow them to be activated by using light. 2D nanomaterials show strong and extended optical absorption in the NIR region, which makes them suitable for light triggered imaging applications, photothermal therapy (PTT), and photodynamic therapy (PDT).…”
Section: Introductionmentioning
confidence: 99%